Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedDec 27, 2017NitroGlycerinStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0119-2018Class IITerminatedDec 27, 2017NitroGlycerinStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0118-2018Class IITerminatedDec 27, 2017NitroGlycerin 100 mcg/mL QS 5% Dextrose InjStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0117-2018Class IITerminatedDec 27, 2017NitroGlycerin 1 mg/10 mL in 5% Dextrose InjStability Data Does Not Support Expiry: lots do not have stability that supports the use of the container system.Advanced Pharma Inc. · D-0116-2018Class ITerminatedDec 27, 2017NitroGlycerinSubpotent Drug: found to be below the specification for labeled assay.Advanced Pharma Inc. · D-0115-2018Class ITerminatedDec 27, 2017NitroGlycerinSubpotent Drug: found to be below the specification for labeled assay.Advanced Pharma Inc. · D-0114-2018Class ITerminatedDec 27, 2017NitroGlycerin 1 mg/10 mL in 5% Dextrose InjSubpotent Drug: found to be below the specification for labeled assay.Advanced Pharma Inc. · D-0113-2018Class IITerminatedDec 27, 20170.25% Acetic Acid Irrigation USPPresence of Particulate Matter: identified as polyethylene, which is consistent with the material used to manufacture the contain capB. Braun Medical Inc · D-0112-2018Class IIITerminatedDec 27, 2017Methylphenidate Hydrochloride Extended-release TabletsSubpotent DrugOsmotica Pharmaceutical Corp · D-0111-2018Class IIITerminatedDec 27, 2017Methylphenidate Hydrochloride Extended-release TabletsSubpotent DrugOsmotica Pharmaceutical Corp · D-0110-2018Class IITerminatedDec 20, 2017Riomet (metformin hydrochloride) Oral Solution Cherry Flavored 500 mg /5 mLMicrobial Contamination of Non-Sterile ProductsSun Pharmaceutical Industries, Inc. · D-0109-2018Class IIITerminatedDec 20, 2017Penicillin V Potassium for Oral SolutionFailed Impurities/Degradation Specifications: high out of specification test results obtained for individual and total impurities.Teva Pharmaceuticals USA · D-0108-2018Class IIITerminatedDec 13, 2017Isradapine Capsules USP 2.5 mgFailed Impurities/Degradation SpecificationsElite Laboratories Inc. · D-0107-2018Class ITerminatedDec 13, 2017grande X 5800 capsuleMarketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0106-2018Class ITerminatedDec 13, 2017FIFTY SHADES 6000 capsuleMarketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0105-2018Class ITerminatedDec 13, 2017PapaZen 3300 capsuleMarketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0104-2018Class ITerminatedDec 13, 2017RHINO 7 Platinum 5000Marketed without an Approved NDA/ANDA: undeclared Active Pharmaceutical Ingredients sildenafil, desmethyl carbodenafil and tadalafil.Gadget Island, Inc · D-0103-2018Class ITerminatedDec 13, 2017Pravastatin Sodium TabletsLabeling: Label mix-up, the product labeled as Pravastatin sodium tablets 40 mg was filled with Bupropion hydrochloride XL Tablets 300 mg.International Laboratories, Inc. · D-0102-2018Class IITerminatedDec 6, 2017Paroxetine Tablets USPPresence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine TabletsZydus Pharmaceuticals USA Inc · D-0101-2018Class IITerminatedDec 6, 2017Vertra Elemental ResistanceCGMP Deviations: products manufactured in a manner that may impact product quality that includes but is not limited to failed viscosity.Eai-Jr286 Inc · D-0100-2018Class IITerminatedDec 6, 2017Levetiracetam Oral SolutionPresence of foreign substance (screw)Hetero Labs, Ltd. - Unit III · D-0099-2018Class IITerminatedDec 6, 2017Liothyronine Sodium TabletsFailed Dissolution Specifications.Mayne Pharma Inc · D-0098-2018Class IIITerminatedDec 6, 2017Duloxetine Delayed-Release Capsules USPFailed Dissolution SpecificationLupin Pharmaceuticals Inc. · D-0097-2018Class IITerminatedDec 6, 2017Clozapine Tablets USPFailed Tablet/Capsule Specifications; potential presence of broken tablets.Teva Pharmaceuticals USA · D-0096-2018Class IITerminatedDec 6, 2017No.1 Faiza Beauty CreamMarketed Without an Approved NDA/ANDANew Reliance Trading, Inc. · D-0095-2018Class IIITerminatedNov 29, 2017Dexamethasone Sodium Phosphate InjectionFailed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).West-Ward Pharmaceuticals Corp. · D-0094-2018Class IIITerminatedNov 29, 2017Dexamethasone Sodium Phosphate InjectionFailed Impurities/Degradation Specifications: high out of specification results for Dexamethasone adduct (related compound).West-Ward Pharmaceuticals Corp. · D-0093-2018Class IITerminatedNov 29, 2017Pravastatin Sodium USPPresence of foreign tablets/capsules: This product lot is being recalled due to a pharmacy complaint where one Duloxetine Delayed Release Capsule, 30mg was found in a...Lupin Limited · D-0092-2018Class IITerminatedNov 29, 2017Paroxetine TabletsPresence of Foreign Tablets/Capsules.Amerisource Health Services · D-0091-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Hemorrhoid Numbing with LidocaineGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0090-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Liquid Hemorrhoid Relief GelGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0089-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Hemorrhoid Numbing Spray with LidocaineGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0088-2018Class IITerminatedNov 29, 2017Extra Strength PreTAT by TAT BALM GelGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0087-2018Class IITerminatedNov 29, 2017Extra Strength Naturally HL Bed Sore Relief Cream with Added LidocaineGMP Deviations: inadequate manufacturing control processesRidge Properties, LLC · D-0086-2018Class IITerminatedNov 29, 2017Lorazepam TabletsLabeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepamLeading Pharma, LLC · D-0085-2018Class IITerminatedNov 29, 2017No. 1 Faiza Beauty CreamMarketed Without an Approved NDA/ANDAShata Trading, Inc. · D-0084-2018Class IITerminatedNov 29, 2017TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mLCGMP DeviationsUnited Therapeutics Corp. · D-0083-2018Class IIITerminatedNov 22, 2017Meclizine hydrochloride tablets USPMarketed without an approved NDA/ANDA: Bottles were released prior to final approval.Jubilant Cadista Pharmaceuticals, Inc. · D-0082-2018Class IITerminatedNov 22, 2017Urin D/S Tablets Methenamine 81.6 mgSuperpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.Llorens Pharmaceutical Corp. · D-0081-2018Class IITerminatedNov 22, 2017Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mLSuperpotent drug: out of specification result for potencyPharMEDium Services, LLC. · D-0080-2018

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.